High-dose therapy with Esomeprazol in combination with Baclofen therapy for symptomatic therapy-resistant gastrooesophageal reflux disease.
- Registry ID
- EUCTR2006-000368-10
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE2
- Sponsor
- Tecnical University of Munich
- Start date
- 2006-08-10
- Completion date
- 2008-10-11
- Last update
- 2026-08-16
Conditions
- Gastroesophageal reflux disease
Summary
Effects of treatment with esomeprazole at twice the standard dose (80 mg), possibly in combination with baclofen, in patients with persistent reflux symptoms after therapeutic elimination of acid reflux following esomeprazole at standard doses?
Locations
View on source registry